NICE Ltd. (NCSYF) director discloses detailed stock option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
NICE Ltd. filed an initial Form 3 for director Dan Michael Falk, detailing his existing stock option holdings in the company’s ordinary shares. The filing lists multiple option awards with different exercise prices and expiration dates ranging from 2026 through 2031.
Some options, including grants covering ordinary shares at exercise prices such as 224.1800 and 144.9030, are fully vested and currently exercisable. One grant is already exercisable for 746 ordinary shares and is scheduled to vest in three substantially equal installments on March 30, 2026, June 30, 2026, and September 30, 2026. Another option grant will fully vest on September 30, 2026. The form records holdings only and does not report new purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
12 transactions reported
Mixed
12 txns
Insider
Falk Dan Michael
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
Holdings After Transaction:
Options — 2,785 shares (Direct)
Footnotes (1)
- The stock option is fully vested and currently exercisable. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026. The stock option will vest on September 30, 2026.
FAQ
What does the NICE Ltd. (NCSYF) Form 3 for Dan Michael Falk report?
The Form 3 reports Dan Michael Falk’s existing stock option holdings in NICE Ltd. ordinary shares. It lists several option grants with specific exercise prices, expiration dates between 2026 and 2031, and notes which options are already vested or will vest on future dates.
Does the NICE Form 3 for Dan Michael Falk show any stock buys or sells?
No, this Form 3 only records existing stock option holdings for Dan Michael Falk. All entries are classified as holdings, with no reported purchases, sales, exercises, gifts, or tax-withholding dispositions in the summarized data for NICE Ltd. ordinary shares.
Which NICE Ltd. options held by Dan Michael Falk are fully vested and exercisable?
The filing states that at least one stock option is fully vested and currently exercisable. Specific examples include options over ordinary shares with exercise prices such as 224.1800 and 144.9030, each tied to defined expiration dates between 2026 and 2031.
How do Dan Michael Falk’s NICE options vest over time according to the Form 3?
One stock option is vested and exercisable for 746 ordinary shares and will vest for remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026, and September 30, 2026. Another option grant is scheduled to vest fully on September 30, 2026.
What are the expiration dates of Dan Michael Falk’s NICE Ltd. stock options?
The reported option grants have expiration dates ranging from September 10, 2026, through September 30, 2031. Each option series in the filing is tied to a specific expiration date, defining how long Dan Michael Falk can choose to exercise those NICE ordinary share options.
What exercise prices are disclosed for Dan Michael Falk’s NICE stock options?
The Form 3 lists several exercise prices for the options over NICE ordinary shares, including amounts such as 224.1800, 232.2005, 197.4245, 168.4643, and 144.9030. Each price corresponds to a distinct option grant with its own vesting and expiration schedule.